Spiration, the Redmond, WA-based medical device company, said today it has promoted Greg Sessler from chief financial officer to chief operating officer. Sessler takes on the new responsibility two months after Spiration won FDA clearance to sell its first product—a tiny valve that doctors insert to block off air to damaged parts of the lung. The initial approval is for a small group of patients who suffer from air leaks after lung surgery, and the company is working to expand the market through a clinical trial of 250 patients with chronic obstructive pulmonary disease.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
